Satellite Symposium 2019 Defining the Cancer Care Ecosystem to Determine Value
Fri May 10th 2019 Bethesda North Marriott Hotel and Conference Center 12:00 pm – 12:30 pm Welcome/Setting the Stage The Evidence Gap Between Regulators and HTA Speaker Paul Kluetz, FDA 12:30 pm – 1:15 pm Lecture Benchmarking Value Scales on Cancer: Compliance with the Criteria for “Accountability for Reasonableness” Speaker Nathan Cherny, ESMO 1:15 pm […]
2019 AAADV WORKSHOP SCHEDULE & AGENDA
May 8th 2019 May 9th 2019 May 10th 2019 Wed May 8th 2019 8:00am – 9:30am Registration for AAADV Workshop; Continental Breakfast 9:30 am – 12:00 pm Moderator Lola Fashoyin-Aje, M.D., M.P.H. ; U.S. Food and Drug Administration Core Curriculum For New Learners Faculty from U.S. Food and Drug Administration: Denise Casey, M.D. Christy Osgood, M.D. […]
Schedule for FDA-Duke Global Pre-Workshop
FDA-Duke Global Regulatory Pre-Workshop White Flint Amphitheater Date: Tuesday, May 7, 2019 8:00 – 8:30 AM Registration/Continental Breakfast 8:30 – 8:35 am Welcome/Introduction/Goals of the Workshop Speaker Ke Liu US FDA 8:35 – 10:05 am Moderator Richard Pazdur, US FDA Session I: International Regulators’ Forum Agnes Chan Singapore HSA Larissa Higgins EMA Representative Jaigi Mathai Health […]
Schedule for AAADV Pre-Workshop for Patient Advocates
Agenda AAADV Pre-Workshop for Patient Advocates Location: Salon H Date: Tuesday, May 7, 2019Time: 12:30 PM-5:00 PM 11:45 AM-12:30 PM Registration 12:30 PM-1:00 PM Introduction/ Challenges and Questions for the Day Speakers H Kim Lyerly, MD DAAD Director and Duke University Mary (Dicey) Jackson Scroggins M.A. (International Gynecologic Cancer Society) Virginia Kwitkowski, MS, ACNP-BC FDA, Div. of […]
Fundamentals Pre-Workshop for Patient Advocates
This custom course is held immediately before the 15th Annual AAADV Workshop and will focus on how advocates can work more effectively with all stakeholders The custom course preceding the 15th Annual AAADV Workshop will provide valuable insights on how advocates can build better relationships with all stakeholders. The course aims to equip participants with the […]
Challenges with Novel Clinical Trial Designs: Master Protocols.
As seen on https://www.ncbi.nlm.nih.gov/pubmed/30696689 Cecchini M1, Rubin EH2, Blumenthal GM3, Ayalew K4, Burris HA5, Russell-Einhorn M6, Dillon H7, Lyerly HK8, Reaman GH9, Boerner S10, LoRusso PM10. The 2018 Accelerating Anticancer Agent Development (AAADV) Workshop assembled a panel of experts for an in-depth discussion session to present Challenges with Novel Clinical Trial Designs. This panel offered assessments of the challenges faced by industry, the Food and […]
15th Annual AAADV Workshop
Leaders in clinical and translational cancer research from academic, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process. May 2-4, 2018
Keynote Speaker Anna Abram
2018 AAADV Keynote Speaker Anna Abram, FDA Deputy Commissioner for Policy, Planning, Legislation and Analysis with Richard Pazdur, M.D., Director of FDA Oncology Center of Excellence.
2018 AAADV Schedule
Click Here – 2019 AAADV Workshop Schedule Wednesday May 2, 2018 Thursday may 3, 2018 Friday May 4, 2018 Wednesday May 2, 2018 08:00 AM – 09:30 AM | Registration/Continental Breakfast 08:30 AM – 12:00 PM | Core CurriculumDrug Development for Early Career Investigators MODERATORTatiana Prowell, M.D. | Early Efficacy Trials, Biomarkers, and Diagnostic Tests SPEAKERTatiana […]
2017 AAADV Schedule
Wednesday May 3, 2017 Thursday May 4, 2017 Friday May 5, 2017 Wednesday May 3, 2017 08:00 AMIntroductions and OverviewH. Kim Lyerly, M.D.AAADV Chair 08:15 AMPlenary Session IA Systems Biology Approach to Cancer Drug Discovery and Development: Master Regulators as Drug TargetsModerator :Gregory Reaman, M.D.; U.S. Food and Drug AdministrationA Systems Biology Approach to Cancer […]